Navigation Links
Baltimore's Mark E. Spier, DPM, Announces FDA Clearance of PinPointe™ FootLaser™ for Treatment of Nail Fungus
Date:10/26/2010

BALTIMORE, Oct. 26 /PRNewswire/ -- The podiatry practice of Mark E. Spier, DPM, announced today that the PinPointe™ FootLaser™ has received clearance from the U.S. Food and Drug Administration (FDA) for the treatment of nail fungus (onychomycosis). Dr. Spier is the first certified provider of the treatment in the Baltimore area.

"Toenail fungus, a condition that affects more than 35 million Americans, is both easily spread and exceptionally durable, often standing up against the most aggressive antifungal pills," said Dr. Spier. "With FDA clearance of the PinPointe FootLaser, patients have a relatively painless, important new treatment option. It is often more successful than topically applied antifungal drugs, has less side effects than oral medication, and is less painful than surgical removal of the nail."

Fungal nail infection is caused by fungus under the nail.  As they grow, fungi feed on keratin, the tough protein that makes up the hard surface of the nails. The nail becomes darker in color and debris may accumulate under the nail. Nail infection can cause nails to be discolored, thickened, brittle, and 'crumbly' and in some people it can interfere with wearing shoes and/or cause pain when walking.

The treatment of nail infection is difficult because the infection is under and inside of the nail, making it hard for any treatment to reach and destroy the infection.  Some people are treated with medicated nail polish or oral medications, which can be associated with side effects and serious drug interactions. Another option is to surgically remove the nail.

About the PinPointe FootLaser

The PinPointe FootLaser is a patented laser device that has been showed in clinical studies to significantly reduce nail infection. The patented PinPointe FootLaser is a specially designed laser beam that goes through the nail and safely reduces the infection in the nail bed that cause onychomycosis. It is FDA cleared and backed by significant clinical research.

The procedure requires one or a small number of safe, quick treatments with little or no discomfort and is performed as an outpatient service with no anesthesia. The gentle laser light beam has no effect on healthy tissue and treats only the infected area.  No drugs or topical ointments are used, eliminating the total-body side effects of traditional oral medications.

About Dr. Mark E. Spier

With 25 years of experience, Dr. Mark E. Spier serves the Baltimore Metropolitan area for all of its podiatry needs. His practice offers care for the full range of foot ailments from fractures to corns. Dr. Spier is certified by the American Board of Podiatric Surgery in forefoot and reconstructive surgery. Visit www.spierfoot.com for more information.

PinPointe and FootLaser are trademarks of PinPointe USA, Inc.


'/>"/>
SOURCE Dr. Mark E. Spier, DPM
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Keryx Biopharmaceuticals Announces Completion of Patient Enrollment In Zerenex Phase 3 Short-Term Study
2. Stereotaxis Announces Third Quarter 2010 Earnings Release Date and Conference Call
3. Rochester Medical Announces Fourth Quarter 2010 Earnings Conference Call Thursday, November 4, 2010
4. NCPA Announces Partnership with Live Oak Bank to Help Finance Independent Community Pharmacy Purchases
5. Trius Announces Issuance of Key U.S. Patent for Torezolid Phosphate
6. Tengion Announces First Implantation of Neo-Urinary Conduit™ in Initial Clinical Trial in Patients with Bladder Cancer
7. Roper Industries Announces Record Third Quarter Results
8. Soligenix Announces Preliminary Results of its Phase 2 Clinical Trial of orBec® in the Prevention of Acute GVHD
9. Sinovac Announces Preliminary Unaudited Third Quarter 2010 Sales Range and Revises Full Year 2010 Sales Expectations
10. NCPA Announces Kathleen Jaeger as CEO
11. Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... , June 23, 2016 Bracket , ... launch its next generation clinical outcomes platform, Bracket eCOA (SM) ... held on June 26 – 30, 2016 in ... first electronic Clinical Outcome Assessment product of its kind to ... #715. Bracket eCOA 6.0 is a flexible platform ...
(Date:6/23/2016)... and INDIANAPOLIS , June ... receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship is any ... scholarship winners, announced today online at www.diabetesscholars.org ... type 1 diabetes stand in the way of academic ... supported the Foundation,s scholarship program since 2012, and continues ...
Breaking Medicine Technology:
(Date:6/24/2016)... Maryland (PRWEB) , ... June 24, 2016 , ... ... Angels is actively feeding the Frederick area economy by obtaining investment capital for ... over the past 2½ years that have already resulted in more than a ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the upcoming 2016 Miss Arizona pageant as its official Medspa Sponsor. Dr. Josh ... Mesa, and Chandler, Arizona. , Dr. Olson says the decision to support ...
(Date:6/24/2016)... ... ... Today, InhaleLabs.com (Inhale) offilially launched its site, which aims to ... high quality water pipes within an ideal price range. The site is completely free ... two brothers, Nick and Mike Hunter, who use medical cannabis to heal ailments of ...
(Date:6/23/2016)... CA (PRWEB) , ... June 23, 2016 , ... An ... that may expose a possible link between head and neck cancer in individuals with ... in the study were evaluated based on whether they had gum disease, brushed their ...
(Date:6/23/2016)... McKinney, Texas (PRWEB) , ... June 23, 2016 , ... ... the special operations community. He turned towards the water to find peace and set ... funds for a veterans charity and turned to the internet. He came across the ...
Breaking Medicine News(10 mins):